Genotype-Phenotype Correlations of β-Thalassemia Mutations in an Azerbaijani Population
Journal Title: Turkish Journal of Hematology - Year 2017, Vol 34, Issue 3
Abstract
β-Thalassemia is the most common inherited disorder in Azerbaijan. The aim of our study was to reveal genotype-to-phenotype correlations of the most common β-thalassemia mutations in an Azerbaijani population. Patients with codon 8 (-AA), IVS-I-6 (T>C), and IVS-II-1 (G>A) mutations, which are reportedly the most common β-globin gene mutations among the local population, were tested for hematologic parameters. Fifty-five previously tested patients with known genotypes were included in the study. Hematologic indices and hemoglobin fractions were tested in order to reveal the phenotypic manifestation of the mutations. The results obtained indicate that clinical presentation varies between different β-globin gene mutations: individuals with IVS-I-6 (T>C) mutations showed milder presentation than those with codon 8 (-AA) and IVS-II-1 (G>A), which is associated with the molecular basis of the mutations. These data can be of assistance to predict clinical presentation and select the best possible therapeutic approach via early genotype identification.
Authors and Affiliations
Chingiz Asadov, Eldar Abdulalimov, Tahira Mammadova, Surmaya Gafarova, Yegana Guliyeva, Gunay Aliyeva
Keywords
Related Articles
- EP ID EP228578
- DOI 10.4274/tjh.2016.0427
- Views 97
- Downloads 0
Different Presentations of Patients with Transcobalamin II Deficiency: A Single-Center Experience from Turkey
Objective: Transcobalamin II deficiency is a rare autosomal recessive disease characterized by decreased cobalamin availability, which in turn causes accumulation of homocysteine and methylmalonic acid. The presenting cl...
A Case of Cutaneous Diffuse Large B-cell Lymphoma
Kasabach-Merritt Syndrome in an Adult: A Comment
.
Acquired Leukocyte Inclusion Bodies Resembling Döhle Bodies During Acute Cholangitis
.
Allogeneic Transplantation In Chronic Myeloid Leukemia And The Effect Of Tyrosine Kinase Inhibitors On Survival, A Quasi-Experimental Study
Objective: Tyrosine kinase inhibitors (TKIs) have changed the indications for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in chronic myeloid leukemia (CML). Therefore, we aimed to evaluate the effect o...